Select the Financial Report:
|
|
Select the Period:
|
|
Description of Steris Plc's Business Segments
Steris Plc stands out as a leading provider of healthcare products, services, and technologies dedicated to enhancing patient safety and improving operational performance across healthcare institutions. The companys comprehensive offerings are categorized into three primary segments: Healthcare Products, Life Sciences Products, and Healthcare Specialty Services. Each segment features an extensive variety of tailored solutions designed to meet the unique demands of healthcare facilities.
1. Healthcare Products
The Healthcare Products segment is essential, offering a broad spectrum of items targeting both critical and non-critical areas in healthcare environments. Key offerings include:
- Surgical Equipment: Steris has developed a diverse range of surgical instruments and devices crucial for various types of surgical procedures. This category encompasses a multitude of tools, including suturing devices, retractors, and electrosurgical units, all of which are designed to enhance the efficacy and safety of surgical interventions. The company emphasizes ergonomic design and reliable performance to support surgeons in delivering optimal outcomes.
- Sterilization Systems: At the core of Steriss commitment to patient safety lies its advanced sterilization technologies. These include steam sterilization, ethylene oxide sterilization, and hydrogen peroxide gaseous plasma technology. Each system is engineered to ensure that medical instruments and equipment are thoroughly sanitized, effectively eliminating harmful microorganisms and thereby facilitating safe surgical environments.
- Infection Prevention Products: The company offers a wide array of infection control products, including antiseptics, disinfectants, and personal protective equipment (PPE). These vital components are integral in reducing the risk of healthcare-associated infections (HAIs), ensuring a safer environment for both healthcare professionals and patients.
- Instrument Tracking and Management Systems: Steris provides innovative tracking solutions that assist healthcare facilities in managing surgical instruments throughout their lifecycle. These systems feature RFID technology and software solutions that allow for real-time tracking of instrument location, usage history, and sterilization status. By improving instrument accountability and operational efficiency, these systems help healthcare organizations maintain compliance with safety standards.
Life Sciences Products
The Life Sciences Products segment is designed to support the rigorous demands of the pharmaceutical and biotechnology sectors, emphasizing research, development, and manufacturing processes. Key offerings include:
- Laboratory Equipment: Steris produces a range of laboratory equipment critical for research and diagnostics. This includes incubators, centrifuges, autoclaves, and biosafety cabinets, all designed to ensure accuracy and safety in laboratory operations. Each product aligns with high industry standards, promoting integrity in experimental results.
- Cleanroom Systems: Steris specializes in designing and constructing cleanroom environments adhering to strict regulatory guidelines essential for pharmaceutical manufacturing. Their cleanroom technology ensures controlled contamination levels, thus providing an optimal environment for the production of sterile products and biotechnological innovations.
- Microbial Reduction Products: This includes an extensive portfolio of sterilants and cleaning agents specifically engineered for laboratory settings. These products play a crucial role in achieving microbial reduction and ensuring that laboratory and manufacturing activities comply with stringent regulatory standards.
Healthcare Specialty Services
In addition to its product offerings, Steris provides specialized services aimed at enhancing operational efficiency and ensuring patient safety within healthcare institutions. Services available include:
- Surgical Instrument Repair: Steris offers professional repair and maintenance services for surgical instruments, allowing healthcare facilities to prolong the lifespan of their tools and uphold the highest safety and performance standards. This service not only provides cost savings by reducing the need for new purchases but also enhances the reliability of surgical instruments.
- Equipment Leasing: Steris facilitates healthcare institutions with leasing options for a diverse array of medical and laboratory equipment. This service allows organizations to access cutting-edge technology without the burden of significant upfront costs, thereby helping to manage budgets more effectively while ensuring operational flexibility.
- Technical Training and Support Services: Steris is committed to providing comprehensive training programs and ongoing technical support for healthcare personnel. These initiatives ensure users are well-versed in the safe operation and maintenance of Steris products, ultimately improving overall operational efficiency and patient safety through knowledgeable and prepared staff.
Commitment to Innovation and Safety
Steris Plcs expansive portfolio reflects its unwavering commitment to delivering innovative, high-quality products and services tailored to the evolving needs of healthcare settings. By integrating state-of-the-art technologies and expert services, Steris endeavors to empower healthcare institutions to enhance patient care, improve operational efficiencies, and reduce overall costs. This holistic approach positions Steris as an invaluable partner for healthcare facilities striving for excellence in patient safety and operational performance.
Composition of Steris Plc Revenues by
Segments |
|
IRELAND |
|
1.76 % |
of total Revenue |
UNITED STATES |
|
73.15 % |
of total Revenue |
Other foreign locations |
|
25.09 % |
of total Revenue |
Healthcare |
|
71.21 % |
of total Revenue |
Healthcare Capital equipment revenues |
|
18.59 % |
of total Revenue |
Healthcare Consumable revenues |
|
26.14 % |
of total Revenue |
Healthcare Sales Revenue Services Net |
|
26.49 % |
of total Revenue |
Applied Sterilization Technologies |
|
18.83 % |
of total Revenue |
Applied Sterilization Technologies Capital equipment revenues |
|
0.37 % |
of total Revenue |
Applied Sterilization Technologies Sales Revenue Services Net |
|
18.47 % |
of total Revenue |
Life Science Member |
|
9.95 % |
of total Revenue |
Life Science Member Capital equipment revenues |
|
2.27 % |
of total Revenue |
Life Science Member Consumable revenues |
|
5.01 % |
of total Revenue |
Life Science Member Sales Revenue Services Net |
|
2.67 % |
of total Revenue |
Q3 three months ended (Dec 31 2024)
|
Revenues by Business Segments |
Revenues (in millions $) |
%
(of total Revenues) |
IRELAND |
24.12 |
1.76 % |
UNITED STATES |
1,002.59 |
73.15 % |
Other foreign locations |
343.87 |
25.09 % |
Healthcare |
976.04 |
71.21 % |
Healthcare Capital equipment revenues |
254.80 |
18.59 % |
Healthcare Consumable revenues |
358.23 |
26.14 % |
Healthcare Sales Revenue Services Net |
363.01 |
26.49 % |
Applied Sterilization Technologies |
258.14 |
18.83 % |
Applied Sterilization Technologies Capital equipment revenues |
5.00 |
0.37 % |
Applied Sterilization Technologies Sales Revenue Services Net |
253.14 |
18.47 % |
Life Science Member |
136.38 |
9.95 % |
Life Science Member Capital equipment revenues |
31.06 |
2.27 % |
Life Science Member Consumable revenues |
68.68 |
5.01 % |
Life Science Member Sales Revenue Services Net |
36.64 |
2.67 % |
Total |
1,370.57 |
100 % |
Q3 three months ended (Dec 31 2024) |
Revenue Growth rates by Segment |
Y/Y Revenue % |
Q/Q Revenue % |
IRELAND |
23.04 % |
- |
UNITED STATES |
5.54 % |
2.35 % |
Other foreign locations |
4.78 % |
5.29 % |
Healthcare |
6.53 % |
3.37 % |
Healthcare Capital equipment revenues |
-4.51 % |
2.03 % |
Healthcare Consumable revenues |
8.74 % |
4.84 % |
Healthcare Sales Revenue Services Net |
13.46 % |
2.9 % |
Applied Sterilization Technologies |
9.88 % |
0.55 % |
Applied Sterilization Technologies Capital equipment revenues |
-4.52 % |
-43.17 % |
Applied Sterilization Technologies Sales Revenue Services Net |
10.21 % |
2.1 % |
Life Science Member |
-6.95 % |
6.59 % |
Life Science Member Capital equipment revenues |
-30.72 % |
34.99 % |
Life Science Member Consumable revenues |
14.32 % |
-4.78 % |
Life Science Member Sales Revenue Services Net |
-12.04 % |
11.69 % |
Total |
-1.8 % |
3.13 % |
Q3 three months ended (Dec 31 2024) |
Income by Business Segments |
Income (in millions $) |
% (Profit Margin) |
Total |
173.29 |
12.64 % |
Q3 three months ended (Dec 31 2024) |
Income Growth rates by Segment |
Y/Y Income % |
Q/Q Income % |
Total |
22.95 % |
14.63 % |
Annual Report on Steris Plc Divisions, Sales by Country |
|
IRELAND |
|
1.97 % |
of total Revenue |
UNITED STATES |
|
73.41 % |
of total Revenue |
Other foreign locations |
|
24.63 % |
of total Revenue |
Healthcare |
|
71.04 % |
of total Revenue |
AST |
|
19.02 % |
of total Revenue |
Life Sciences |
|
9.93 % |
of total Revenue |
Healthcare Segment |
|
71.04 % |
of total Revenue |
Capital equipment Healthcare Segment |
|
19 % |
of total Revenue |
Capital equipment AST |
|
0.57 % |
of total Revenue |
Capital equipment Life Sciences |
|
2.15 % |
of total Revenue |
Consumables Healthcare Segment |
|
25.57 % |
of total Revenue |
Consumables Life Sciences |
|
5.25 % |
of total Revenue |
Service Healthcare Segment |
|
26.48 % |
of total Revenue |
Service AST |
|
18.46 % |
of total Revenue |
Service Life Sciences |
|
2.53 % |
of total Revenue |
Twelve months ended 2025
|
STE s Annual Revenue by Geography and Business Segments |
Sales (in millions $) |
% (of total Sales) |
IRELAND |
107.32 |
1.97 % |
UNITED STATES |
4,007.62 |
73.41 % |
Other foreign locations |
1,344.57 |
24.63 % |
Healthcare |
3,878.67 |
71.04 % |
Total |
5,459.52 |
100 % |
AST |
1,038.57 |
19.02 % |
Life Sciences |
542.27 |
9.93 % |
Healthcare Segment |
3,878.67 |
71.04 % |
Capital equipment Healthcare Segment |
1,037.20 |
19 % |
Capital equipment AST |
30.95 |
0.57 % |
Capital equipment Life Sciences |
117.53 |
2.15 % |
Consumables Healthcare Segment |
1,396.03 |
25.57 % |
Consumables Life Sciences |
286.66 |
5.25 % |
Service Healthcare Segment |
1,445.44 |
26.48 % |
Service AST |
1,007.63 |
18.46 % |
Service Life Sciences |
138.08 |
2.53 % |
Twelve months ended 2025
|
STE s Annual Income by Country and Business Segments |
Income (in millions $) |
% (Profit Margin) |
Total |
616.07 |
11.28 % |
Twelve months ended 2025
|
Annual Revenue and Income Growth by Country and Business Segments |
% Y/Y Sales Growth |
% Y/Y Income Growth |
IRELAND |
29.78 % |
- |
UNITED STATES |
6.83 % |
- |
Other foreign locations |
3.07 % |
- |
Healthcare |
7.35 % |
- |
Total |
6.24 % |
62.09 % |
AST |
8.87 % |
- |
Life Sciences |
-5.15 % |
- |
Healthcare Segment |
7.35 % |
- |
Capital equipment Healthcare Segment |
-4.98 % |
- |
Capital equipment AST |
113.14 % |
- |
Capital equipment Life Sciences |
-24.43 % |
- |
Consumables Healthcare Segment |
11.82 % |
- |
Consumables Life Sciences |
13.94 % |
- |
Service Healthcare Segment |
13.54 % |
- |
Service AST |
7.26 % |
- |
Service Life Sciences |
-16.11 % |
- |
|
|